Naloxone is emergency overdose reversal support
CDC materials describe naloxone as a medication that can reverse opioid overdose. Emergency services should still be contacted during a suspected overdose.
Naloxone is a medicine that can reverse an opioid overdose. People who use opioids, take OUD medication or may be around someone at risk should discuss access and learn how to respond. You can also obtain over-the-counter naloxone products without waiting for a clinic appointment. The specific product and dispensing pathway determine whether a prescription is needed.
Naloxone blocks opioid effects and can restore breathing during an opioid overdose. Its effects can wear off before those of the opioid, so emergency assessment is still needed. It does not provide ongoing OUD treatment or directly treat stimulant toxicity. It can be useful when fentanyl is mixed with cocaine, methamphetamine or an unknown pill because an opioid overdose may occur without the person expecting opioid exposure.
Discuss naloxone if opioids are used or prescribed, there is a previous overdose, multiple sedating substances are involved, or opioid tolerance may have fallen. Risk can increase after time without use, discharge, a treatment gap or stopping naltrexone. Family, friends and other people who may witness an overdose can also learn the response. The right product and instructions should be reviewed before an emergency.
Ask a pharmacist or clinician about OTC and other local access pathways. Confirm the specific device, expiration and storage instructions. Keep it somewhere that the people likely to help can find it promptly. Do not assume instructions for one nasal spray or injectable product match every product.
A person who cannot be awakened or has slow, shallow or absent breathing may be having an overdose. Other signs can include choking or gurgling sounds and discolored lips or nails. If uncertain but an opioid overdose is possible, respond promptly rather than waiting for proof of what was taken.
Administer available naloxone according to the product instructions and call 911. Tell the dispatcher what is happening and follow instructions for breathing support or CPR. More naloxone may be needed, especially with fentanyl. Repeat according to the product directions and emergency guidance.
Stay with the person until help arrives. Breathing problems can return after apparent improvement because naloxone may wear off. Do not assume that waking up means emergency care is unnecessary. Once immediate safety is addressed, discuss treatment, access barriers and another naloxone supply.
Review the device with a pharmacist or healthcare professional and share the plan with trusted people. Check that they know where it is stored. Replace expired, used or damaged products as appropriate. If you live alone, discuss practical ways to reduce overdose risk; carrying naloxone does not guarantee that you can administer it to yourself during unconsciousness.
Possible overdose is an emergency. Call 911 and use available naloxone. Do not wait for an appointment, insurance confirmation or a prescription. Naloxone may cause sudden withdrawal in a person dependent on opioids, but saving breathing takes priority. Emergency monitoring is required even after an apparent response. It does not make high-risk opioid or sedative combinations safe.
After any overdose, obtain medical assessment and review the treatment plan. Discuss what led to the exposure, whether OUD medication is needed or interrupted, and how another supply of naloxone will be obtained. Review lower tolerance and risk after a period without opioids. A naloxone visit should connect to ongoing care when wanted and clinically appropriate, while keeping emergency access straightforward.
Ask a pharmacist about OTC availability or other dispensing pathways and what the actual product costs or coverage may be. Local programs may also provide naloxone, but their availability needs confirmation. Confirm whether the specific service has naloxone available and what it costs. If the clinic does not have it, ask about another verified access source; do not delay responding to an overdose.
Naloxone is a medicine that can reverse an opioid overdose. People who use opioids, take OUD medication or may be around someone at risk should discuss access and learn how to respond. You can also obtain over-the-counter naloxone products without waiting for a clinic appointment. The specific product and dispensing pathway determine whether a prescription is needed.
Naloxone blocks opioid effects and can restore breathing during an opioid overdose. Its effects can wear off before those of the opioid, so emergency assessment is still needed. It does not provide ongoing OUD treatment or directly treat stimulant toxicity. It can be useful when fentanyl is mixed with cocaine, methamphetamine or an unknown pill because an opioid overdose may occur without the person expecting opioid exposure.
Discuss naloxone if opioids are used or prescribed, there is a previous overdose, multiple sedating substances are involved, or opioid tolerance may have fallen. Risk can increase after time without use, discharge, a treatment gap or stopping naltrexone. Family, friends and other people who may witness an overdose can also learn the response. The right product and instructions should be reviewed before an emergency.
Discuss naloxone if opioids are used or prescribed, there is a previous overdose, multiple sedating substances are involved, or opioid tolerance may have fallen. Risk can increase after time without use, discharge, a treatment gap or stopping naltrexone. Family, friends and other people who may witness an overdose can also learn the response. The right product and instructions should be reviewed before an emergency.
Ask a pharmacist or clinician about OTC and other local access pathways. Confirm the specific device, expiration and storage instructions. Keep it somewhere that the people likely to help can find it promptly. Do not assume instructions for one nasal spray or injectable product match every product.
A person who cannot be awakened or has slow, shallow or absent breathing may be having an overdose. Other signs can include choking or gurgling sounds and discolored lips or nails. If uncertain but an opioid overdose is possible, respond promptly rather than waiting for proof of what was taken.
Administer available naloxone according to the product instructions and call 911. Tell the dispatcher what is happening and follow instructions for breathing support or CPR. More naloxone may be needed, especially with fentanyl. Repeat according to the product directions and emergency guidance.
Stay with the person until help arrives. Breathing problems can return after apparent improvement because naloxone may wear off. Do not assume that waking up means emergency care is unnecessary. Once immediate safety is addressed, discuss treatment, access barriers and another naloxone supply.
Possible overdose is an emergency. Call 911 and use available naloxone. Do not wait for an appointment, insurance confirmation or a prescription. Naloxone may cause sudden withdrawal in a person dependent on opioids, but saving breathing takes priority. Emergency monitoring is required even after an apparent response. It does not make high-risk opioid or sedative combinations safe.
No. Naloxone reverses an opioid overdose. It does not provide ongoing treatment for opioid use disorder or replace Suboxone, Sublocade or Vivitrol. Those medicines have separate treatment roles and starting requirements. Keep a reversal product available when relevant while following the clinician's ongoing care plan. During a suspected overdose, use it according to its directions and call 911.
Call 911 for suspected overdose, slow breathing, inability to wake, a seizure, severe confusion or immediate danger. Give available naloxone for a suspected opioid overdose and stay with the person while emergency help is called. Emotional distress without immediate medical danger also warrants prompt crisis support and a safety assessment. A routine booking or medication visit should not delay emergency care.
No. OTC naloxone products are available without a prescription. Other products or coverage pathways may involve a prescription or standing-order process. Ask about the specific product and local access.
Naloxone is available as a nasal spray and as injectable products. A ready-to-use nasal spray is an option for a bystander responding to a suspected opioid overdose; medical professionals may use an injection according to the product and setting. There is no one best route for every situation. Use the actual device’s instructions, call 911 and stay with the person. Do not wait for a preferred formulation before using available naloxone.
Call 911 or have someone call while you give naloxone. Lay the person on their back, insert the single-dose spray tip into one nostril as its instructions show, and press the plunger. Do not prime or test the spray first. If normal breathing does not return, or symptoms return, give another dose with a new device every 2–3 minutes, alternating nostrils, until emergency help arrives. Stay with the person and follow the dispatcher’s breathing or CPR instructions. Nasal instructions do not apply to an injectable product.
Naloxone is the active medicine; Narcan is one brand of naloxone nasal spray. Other naloxone products have different brands, strengths or devices. Read the instructions for the product you have rather than assuming every device is used the same way. All require emergency response for a suspected overdose; the naloxone ingredient in Suboxone does not replace a separate rescue product.
Its effect is temporary, often described as about 30–90 minutes, and may wear off before the opioid does. Breathing problems can return even after a person wakes up. Call 911, stay with them and give repeat doses according to the product instructions if needed. That time range is not a safe waiting period, and it cannot replace emergency monitoring.
CDC materials describe naloxone as a medication that can reverse opioid overdose. Emergency services should still be contacted during a suspected overdose.
Patients still need a treatment plan when opioid use disorder, withdrawal, relapse risk, or ongoing opioid exposure is part of the picture.
Suboxone, Sublocade, and VIVITROL care addresses treatment options; naloxone addresses emergency overdose response risk.
Patients may want naloxone access and education for people close to them, especially when fentanyl exposure or relapse risk is possible.
Bronx
932 E 174th St, Bronx, NY 10460
Local MAT access for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone careQueens
37-15 23rd Ave, Astoria, NY 11105
Local MAT access for patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Bronx
2063A Bartow Ave, Bronx, NY 10475
Local MAT access for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
Local MAT access for patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Long Island
232 W Old Country Rd, Hicksville, NY 11801
Local MAT access for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
Local MAT access for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
Local MAT access for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Queens
30-07 36th Ave, Astoria, NY 11106
Local MAT access for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Long Island
135 Mineola Blvd, Mineola, NY 11501
Local MAT access for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Manhattan
259 1st Ave, New York, NY 10003
Local MAT access for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone care
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
Local MAT access for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods, with Suboxone, bridge-review, insurance, and follow-up pathways available through Nao Medical.
View local MAT care View Suboxone careReview online Suboxone treatment options in NYC with Nao Medical, including telemedicine evaluation, insurance review, follow-up planning, and in-person backup when needed.
Find buprenorphine treatment for opioid use disorder in NYC with Nao Medical, including Suboxone care, induction planning, follow-up, insurance review, and local MAT locations.
Find opioid de-addiction medicine in NYC with Nao Medical, including opioid use disorder assessment, medication options, Suboxone care, naloxone safety planning, and follow-up.
Compare Suboxone, Sublocade, and VIVITROL treatment pathways in NYC with Nao Medical, including buprenorphine, monthly injections, opioid-free timing, insurance, and follow-up planning.
Buprenorphine-naloxone evaluation, medication planning, and ongoing follow-up.
Evaluation of oral and long-acting buprenorphine options for opioid use disorder.
Monthly extended-release buprenorphine evaluation, access coordination, and in-clinic administration planning.
Weekly or monthly extended-release buprenorphine evaluation, coverage coordination, and treatment planning.
Extended-release naltrexone evaluation for opioid or alcohol use disorder when clinically appropriate.
Fast assessment without promising that medication can or should start before timing and safety are reviewed.
Assessment of withdrawal, product type, 7-OH exposure, opioid overlap, and appropriate next steps.
How naloxone works, available forms, overdose signs, repeat dosing, and emergency response.
Clinical and patient resources for offering naloxone and reducing overdose risk.
Current New York access rules, pharmacy dispensing, insurance information, and lower-cost options.
Arrange an evaluation to discuss suitable care, preparation and follow-up with a clinician.
Book overdose-prevention visit